These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 798193)

  • 41. The Gemfibrozil Study.
    Manninen V
    Acta Med Scand Suppl; 1985; 701():83-8. PubMed ID: 3907298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and bioavailability of simfibrate a new clofibric acid derivative.
    Harvengt C; Desager JP
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):145-151. PubMed ID: 812660
    [No Abstract]   [Full Text] [Related]  

  • 43. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gemfibrozil--a new lipid lowering agent.
    Hodges RM
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):1-2. PubMed ID: 798192
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term effect of halofenate on serum lipids.
    Aronow WS; Vangrow J; Pagano J; Khemka M; Vawter M; Papageorge's NP
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):897-903. PubMed ID: 4214664
    [No Abstract]   [Full Text] [Related]  

  • 46. Summary of present data from a clinical trial of CI-719.
    Wilkening J; Schwandt P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):90-3. PubMed ID: 1019158
    [No Abstract]   [Full Text] [Related]  

  • 47. Design, synthesis and hypolipidemic activity of novel 2-(m-tolyloxy) isobutyric acid derivatives.
    Idrees GA; Abuo-Rahma Gel-D; Aly OM; Radwan MF
    Eur J Med Chem; 2009 Jun; 44(6):2679-84. PubMed ID: 19121550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of Regelan (Atromid-S) on serum lipids and platelet aggregation in occlusive arterial disease].
    Fischer M; Irsigler K
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):248-51. PubMed ID: 4880993
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of lormetazepam on glycemia and serum lipids in hyperlipidemic rats.
    Horák J; Horák A; Lenghel A; Cuparencu B
    Acta Physiol Hung; 1997-1998; 85(1):77-82. PubMed ID: 9530438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipidaemic models of Wistar albino rats.
    Vijaya C; Ramanathan M; Suresh B
    Indian J Exp Biol; 2009 Mar; 47(3):182-5. PubMed ID: 19405383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR
    Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antihyperlipaemic activity of some 2-aminomethyl-3-aryl-5,6,7,8-tetrahydrobenzo(b)/5,6-dimethylthieno++ +(2,3- d) -pyrimidin-4-ones.
    Gadad AK; Kapsi SG; Anegundi RI; Pattan SR; Mahajanshetti CS; Shishoo CJ
    Arzneimittelforschung; 1996 Oct; 46(10):981-5. PubMed ID: 8931892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Editorial on CHD.
    Riesen WF
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S1-2. PubMed ID: 9044998
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 57. Xylene.
    IARC Monogr Eval Carcinog Risks Hum; 1989; 47():125-56. PubMed ID: 2699895
    [No Abstract]   [Full Text] [Related]  

  • 58. Photosensitized hydration of cholesterol.
    Waters JA; Witkop B
    J Org Chem; 1969 Dec; 34(12):3774-8. PubMed ID: 5357521
    [No Abstract]   [Full Text] [Related]  

  • 59. [Conformation of valeranone and derivatives].
    Hikino H; Takeshita Y; Hikino Y; Takemoto T
    Yakugaku Zasshi; 1967 Sep; 87(9):1035-9. PubMed ID: 5627422
    [No Abstract]   [Full Text] [Related]  

  • 60. The Toleration of Arsenic.
    Mackenna RW
    Br Med J; 1901 Jan; 1(2089):85. PubMed ID: 20759385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.